UBS Maintains Neutral on Exelixis, Raises Price Target to $52
Benzinga Newsdesk 4 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Ashwani Verma maintains Exelixis (NASDAQ:EXEL) with a Neutral and raises the price target from $43 to $52.
UBS analyst Ashwani Verma maintains Exelixis (NASDAQ:EXEL) with a Neutral and raises the price target from $43 to $52.